Home / RGP1 Knockout Cell Lines

RGP1 Knockout Cell Lines

Gene: RGP1

Official Full Name: RGP1 homolog, RAB6A GEF complex partner 1provided by HGNC

Gene Summary: Enables guanyl-nucleotide exchange factor activity and small GTPase binding activity. Involved in negative regulation of protein catabolic process; positive regulation of GTPase activity; and retrograde transport, endosome to Golgi. Located in cytosol and plasma membrane. Part of Ric1-Rgp1 guanyl-nucleotide exchange factor complex. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO32696 RGP1 Knockout cell line (HeLa) Human RGP1 1:3~1:6 Negative Online Inquiry
KO32697 RGP1 Knockout cell line (HCT 116) Human RGP1 1:2~1:4 Negative Online Inquiry
KO32698 RGP1 Knockout cell line (HEK293) Human RGP1 1:3~1:6 Negative Online Inquiry
KO32699 RGP1 Knockout cell line (A549) Human RGP1 1:3~1:4 Negative Online Inquiry

Background

RGP1 Gene Knockout Cell Lines are advanced biological research tools designed to facilitate the study of gene function and regulation by enabling targeted deletions of the RGP1 gene. This innovative product utilizes CRISPR-Cas9 technology, which allows for precise and efficient editing of the cellular genome. By knocking out the RGP1 gene, researchers can effectively analyze the phenotypic consequences of gene loss, investigate pathways influenced by RGP1, and explore its role in cellular processes such as proliferation, differentiation, and stress response.

The key mechanism of RGP1 Gene Knockout Cell Lines lies in their ability to create a null mutation of the RGP1 gene, thereby eliminating its expression in a controlled cellular environment. This knockout approach provides an unparalleled platform for functional genomics that allows researchers to observe the direct effects of RGP1 deficiency on cellular behavior and molecular interactions. In clinical settings, these cell lines can expedite the identification of potential therapeutic targets for diseases associated with RGP1 dysregulation.

What sets our RGP1 Gene Knockout Cell Lines apart from alternative gene editing products is their high efficiency and specificity, coupled with rigorous validation to ensure reproducibility in experiments. The precision of CRISPR technology minimizes off-target effects, making these cell lines reliable for sensitive applications. The availability of these knockout models not only aids in basic research but also accelerates drug discovery and development by providing critical insights into gene function and associated pathways.

Researchers and clinicians benefit from using RGP1 Gene Knockout Cell Lines as they deliver definitive insights into the biological role of the RGP1 gene, ultimately driving innovative approaches in biomedical research. The product enhances experimental rigor and yields reproducible results, making it integral to advancing scientific knowledge and therapeutic strategies.

By leveraging our extensive expertise in the field of molecular biology and genetic engineering, our company is committed to providing researchers with cutting-edge tools and supports the scientific community's goals through innovative product offerings like the RGP1 Gene Knockout Cell Lines.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.